Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation

Transplantation Proceedings

Volumn 42, Issue 2, 2010, Pages 660-662

  Valdivieso, A ^a   Bustamante, J ^a   Gastaca, M ^a   Uriarte, J G ^a   Ventoso, A ^a   Ruiz, P ^a   Fernandez, J R ^a   Pijoan, I ^a   Testillano, M ^a   Suarez, M J ^a   Montejo, M ^a   Ortiz de Urbina, J ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; EVEROLIMUS; SORAFENIB; TACROLIMUS;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PALLIATIVE THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; TIME FACTORS; WAITING LISTS;

EID: 77949440307     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.02.014     Document Type: Article

References (7)

1. Roayaie S., Schwartz J.D., Sung M.W., et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 10 (2004) 534
2. Hollebecque A., Decaens T., Boleslawski E., et al. Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation. Gastroentrol Clin Biol 33 (2009) 361
3. Schwartz M., Roayaie S., and Llovet J. How should patients with hepatocellular carcinoma after liver transplantation be treated?. J Hepatol 43 (2005) 584
4. Regalia E., Fassati L.R., Valente U., et al. Pattern and management of recurrent hepatocellular carcinoma alter liver transplantation. J Hepatobiliary Pancreat 5 (1998) 29
5. Zimmerman M.A., Trotter J.F., Wachs M., et al. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver Transpl 14 (2008) 633
6. Llovet J.M., Ricci S., Mazzaferro V., et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359 (2008) 378
7. Newell P., Toffanin S., Villanueva A., et al. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol 51 (2009) 725